Clinical Trial Update: Pharmacokinetics and Safety of BI 1744 CL Plus Tiotropium Bromide in Chronic Obstructive Pulmonary Disease (COPD) [Phase 1]

View source ↗

Summary

Phase 1 study reports pharmacokinetics and safety of BI 1744 CL when combined with tiotropium bromide in chronic obstructive pulmonary disease, providing initia…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• BI 1744 CL
• tiotropium bromide (tiotropium)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 1 | Status: COMPLETED | Results posted: 2016-01-07